| Application no. and date | 98962011.7 (espacenet) (Federated) (European Patent Register), 19981209 | | Patent/reg. no. and date | DK/EP 1039887, 20060524 | | Publication date | 20001004 | | Priority no. and date | US 987550, 19971209 | | EP pub. no. and date |
EP 1039887 20001004 | | Effective date | | | Applicant/owner | Medimmune Oncology, Inc., One Tower Bridge,
100 Front Street
West Conshohocken, PA 19428, US,
The Arizona Board of Regents, 888 North Euclid Avenue,
Room 204
Tucson, AZ 85721-0158, US | | Applicant ref. no. | P40365DK01 | | Inventor | STOGNIEW, Martin, 1870 Ferguson Lane
Blue Bell, PA 19422, US,
ALBERTS, David, S., 250 North Indian House Road
Tucson, AZ 85711, US,
KAPLAN, Edward, H., 9116 Kenneth Avenue
Skokie, IL 60076, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/095 (2006.01) , A61K 31/16 (2006.01) | | Title | Anvendelse af aminothiolforbindelser til behandling af neuro- og nefrolidelser og terapeutiske toksiciteter | | Int. application no. | US1998026096 | | Int. publication no. | WO1999029312 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
